Company page

Ovid Therapeutics Inc.

Ovid Therapeutics Inc. is a public company traded under the ticker OVID in the American market. The company has a market capitalization of approximately $434.87 million. Ovid Therapeutics focuses on developing innovative therapies for neurological disorders.